|本期目录/Table of Contents|

[1]赵珍珍 综述,邓靖宇 审校.蛋白质组学技术在胃癌研究中的应用[J].天津医科大学学报,2021,27(01):94-98.
点击复制

蛋白质组学技术在胃癌研究中的应用(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年01期
页码:
94-98
栏目:
综述
出版日期:
2021-01-20

文章信息/Info

Title:
-
文章编号:
1006-8147（2021）01-0094-05
作者:
赵珍珍 综述; 邓靖宇 审校
天津医科大学肿瘤医院胃部肿瘤科，国家肿瘤临床医学研究中心，天津市“肿瘤防治”重点实验室，天津市恶性肿瘤临床医学研究中心，天津300060
Author(s):
-
关键词:
胃癌; 蛋白质组学; 生物标志物
Keywords:
-
分类号:
R735.2
DOI:
-
文献标志码:
A
摘要:
根据世界卫生组织的数据，胃癌是世界上第三大癌症相关死亡原因。尽管诊断和治疗技术日新月异，大多数胃癌病例都是进展期确诊的，治疗效果欠佳,所以胃癌的早期诊断、早期治疗对于改善胃癌患者的预后非常关键。蛋白质组学正高速发展，研究显示在基因、细胞、组织、个人和群体水平上表达的人类蛋白质组存在巨大复杂性。近年来，研究者利用先进的蛋白质组学技术，将胃癌患者和健康对照者的样本进行差异分析,寻找新的、可靠的肿瘤标志物，对胃癌的早期诊断、预后预测和靶向治疗具有重要意义。
Abstract:
-

参考文献/References:

[1] Bray F，Ferlay J，Soerjomataram I， et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2018，68（6）：394
[2] Marrelli D，Polom K，De Manzoni G， et al.Multimodal treatment of gastric cancer in the West：Where are we going?[J].World J Gastroenterol，2015，21（26）：7954
[3] Sheynkman G M，Shortreed M R，Cesnik A J，et al. Proteogenomics：integrating Next-Generation sequencing and mass spectrometry to characterize human proteomic variation[J]. Annu Rev Anal Chem（Palo Alto Calif），2016，9（1）：521
[4] Wasinger V C，Cordwell S J，Cerpa-Poljak A， et al. Progress with gene-product mapping of the mollicutes：mycoplasma genitalium[J].Electrophoresis，1995，16（7）：1090
[5] Repetto O，Maiero S，Magris R，et al. Quantitative proteomic approach targeted to fibrinogen β chain in tissue gastric carcinoma[J]. Int J Mol Sci，2018，19（3）：759
[6] Suarez G，Romero-Gallo J，Piazuelo M B，et al. Modification of helicobacter pylori peptidoglycan enhances NOD1 activation and promotes cancer of the stomach[J]. Cancer Res，2015，75（8）：1749
[7] Hutchens T W.Erratum to：10th asilomat conference on mass spectrometry：time of flight mass spectrometry[J]. J Am Soc Mass Spectrom，1993，4（7）：612
[8] Zhang H，Li H，Guo F，et al. Screen and identification of serum protein biomarkers in gastric cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi，2016，19（3）：317
[9] Ao K，Robert A. Binary markov random fields and interpretable mass spectra discrimination[J]. Stat Appl Genet Mol Biol，2017，16（1）：13
[10] Alan K W，Boon-Kiong L，Norhaniza A，et al. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial，ovarian and cervical cancer[J]. Arch Physiol Biochem，2016，122（3）：111
[11] Guda M R，Rashid M A，Asuthkar S，et al. Pleiotropic role of macrophage migration inhibitory factor in cancer[J]. Am J Cancer Res，2019， 9（12）：2760
[12] Mohri Y，Toiyama Y，Kusunoki M.Progress and prospects for the discovery of biomarkers for gastric cancer：a focus on proteomics[J].Expert Rev Proteomics，2016，13（12）：1131
[13] Yoo M W，Park J，Han H S，et al. Discovery of gastric cancer specific biomarkers by the application of serum proteomics[J]. Proteomics，2017，17（6）：1600332
[14] Saraswat M，Joenv?覿?覿r?覿 S，Sepp?覿nen H，et al. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis[J]. Cancer Med，2017，6（7）：1738
[15] Mato J M，Elortza F，Lu S C，et al. Liver cancer-associated changes to the proteome：what deserves clinical focus[J]. Expert Rev Proteomics，2018，15（9）：749
[16] Shi F，Wu H，Qu K，et al. Identification of serum proteins AHSG，FGA and APOA-Ⅰ as diagnostic biomarkers for gastric cancer[J]. Clin Proteomics，2018，15：18
[17] Aebersold R，Goodlett D R. Mass spectrometry in proteomics[J]. Chem Rev，2001，101（2）：269
[18] Seger C，Salzmann L. After another decade：LC-MS/MS became routine in clinical diagnostics[J]. Clin Biochem，2020，82（11）：2
[19] Jiang Z，Sun X，Zhang Q，et al. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis[J]. Clin Chim Acta，2017，471：29
[20] Alcolea-Medina A，Fernandez M，Montiel N，et al. An improved simple method for the identification of Mycobacteria by MALDI-TOF MS（Matrix-Assisted Laser Desorption- Ionization mass spectrometry）[J]. Sci Rep，2019，9（1）：20216
[21] Mcgarvey P B，Nightingale A，Luo J，et al. UniProt genomic mapping for deciphering functional effects of missense variants[J]. Hum Mutat，2019，40（6）：694
[22] Wu D，Zhang P L，Ma J，et al. Serum biomarker panels for the diagnosis of gastric cancer[J]. Cancer Med，2019，8（4）：1576
[23] Su X，Ye Z，Wang Z，et al. Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer[J]. Virus Res，2018，256（17）：1
[24] Skinner W S，Phinney B S，Herren A，et al. Using LC-MS based methods for testing the digestibility of a nonpurified transgenic membrane protein in simulated gastric fluid[J]. J Agric Food Chem，2016，64（25）：5251
[25] Wei W，Wen W Y，Maxey C C. A simple biomarker scoring matrix for early gastric cancer detection[J]. Proteomics，2016，16（22）：2921
[26] Seo S，Ryu M H，Park Y S，et al. Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients：results of the GASTric cancer HER2 reassessment study 3（GASTHER3）[J]. Gastric Cancer，2019，22（3）：527
[27] Momynaliev Kuvat T，Kashin Sergey V，Chelysheva Vera V，et al. Functional divergence of Helicobacter pylori related to early gastric cancer[J]. J Proteome Res，2010，9：254
[28] Yumnam S，Raha S，Kim S M，et al. Identification of a novel biomarker in tangeretin-induced cell death in AGS human gastric cancer cells[J]. Oncol Rep，2018，40（6）：3249
[29] Chen J，Wang L，Wu F F，et al. Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy[J]. Echocardiography，2019，36（9）：1682
[30] Mork M，Quesada P R，Bannon S，et al. Pancreatic cancer early detection and interception in an atypical case of Peutz-Jeghers syndrome[J]. Pancreas，2019，48（4）：e29
[31] Roointan A，Ahmad M T，Ibrahim W S，et al. Early detection of lung cancer biomarkers through biosensor technology：a review[J]. J Pharm Biomed Anal，2018，164（10）：17
[32] Lan P，Jing W，Yong F，et al. Correlations of TNM staging and lymph node metastasis of gastriccancer with MRI features and VEGF expression[J]. Cancer Biomark，2018，23（1）：53
[33] Booth W T，Walker N B，Lowther W T，et al. Cannabinoid receptor interacting protein 1a（CRIP1a）：function and structure[J]. Molecules，2019，24（20）：3672
[34] Park J S，Lee N，Beom S H，et al. The prognostic value of volume-based parameters using（18）F-FDG PET/CT in gastric cancer according to HER2 status[J]. Gastric Cancer，2018，21（2）：213
[35] Cai Z，Zhao J S，Li J J，et al. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism[J]. Mol Cell Proteomics，2010，9（12）：2617

相似文献/References:

[1]刘新兰,李淑璟,张海霞.候选抑癌基因RASSF6在胃癌组织中的表达及其与临床病理特征的关系[J].天津医科大学学报,2015,21(04):287.
　LIU Xin -lan,LI Shu -jing,ZHANG Hai -xia.Expressions of RASSF6 in gastric cancer and its association with clinicopathologic feature[J].Journal of Tianjin Medical University,2015,21(01):287.
[2]李 静,孙保存,孙 冉,等.环氧合酶2通过上皮间质转换促进胃癌的侵袭与转移 [J].天津医科大学学报,2016,22(03):185.
　LI Jing,SUN Bao-cun,SUN Ran,et al.Cyclooxygenase-2 promotes gastric cancer invasion and metastasis by inducing epithelial to mesenchymal transition[J].Journal of Tianjin Medical University,2016,22(01):185.
[3]郭江涛综述,邓靖宇审校.胃癌淋巴结转移的分子标志物研究进展[J].天津医科大学学报,2017,23(01):85.
[4]赵忠治,王金淼,魏颖,等.术前外周血NLR与PLR对胃癌预后的评估价值[J].天津医科大学学报,2018,24(01):50.
　ZHAO Zhong-zhi,WANG Jin-miao,WEI Ying,et al.Evaluation value?of preoperative peripheral blood NLR and PLR? on prognosis of? gastric cancer[J].Journal of Tianjin Medical University,2018,24(01):50.
[5]张 悦,管叙文,王婧雅,等.miR-27a对胃癌细胞凋亡影响的体外研究[J].天津医科大学学报,2018,24(06):469.
　ZHANG Yue,GUAN Xu-wen,WANG Jing-ya,et al.Influence of miR-27a on apoptosis of gastric cancer cells in vitro[J].Journal of Tianjin Medical University,2018,24(01):469.
[6]白惠惠,邓靖宇,梁 寒.血清肿瘤标志物对胃癌淋巴结转移的诊断价值[J].天津医科大学学报,2019,25(03):241.
　BAI Hui-hui,DENG Jing-yu,LIANG Han.Prognostic value of serum tumor biomarkers for lymph node metastasis of gastric cancer[J].Journal of Tianjin Medical University,2019,25(01):241.
[7]张灿灿,谭志军.FMNL2在胃癌组织中的表达及其临床意义[J].天津医科大学学报,2020,26(02):149.
　ZHANG Can-can,TAN Zhi-jun.Expression and clinical significance of FMNL2 in gastric cancer[J].Journal of Tianjin Medical University,2020,26(01):149.
[8]昕宇 综述,邓靖宇,梁寒 审校.主动脉旁淋巴结清扫术在进展期胃癌治疗中的研究进展[J].天津医科大学学报,2021,27(01):99.
[9]左兴盛,宋志玉,贾海盼,等.沉默circPVT1对5-氟尿嘧啶耐药胃癌细胞化疗增敏作用及机制研究[J].天津医科大学学报,2021,27(06):574.
　ZUO Xing-sheng,SONG Zhi-yu,JIA Hai-pan,et al.The sensitizing effect and mechanism of silencing of circPVT1 on 5-fluorouracil chemosensitivity in gastric cancer cells[J].Journal of Tianjin Medical University,2021,27(01):574.
[10]赵路瑶 综述,李慕然,刘艳迪 审校.外周血SEPT9基因甲基化检测在胃癌诊断中的研究进展[J].天津医科大学学报,2022,28(02):218.

备注/Memo

备注/Memo:
作者简介 赵珍珍（1997-），女，硕士在读，研究方向：肿瘤学；通信作者：邓靖宇，E-mail: dengery@126.com
更新日期/Last Update: 2021-01-10